James N Fleming (James Fleming, J N Fleming)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 17

Top Topics

African American

Kidney Transplantation

Epstein Barr Virus

Top Venues

JMIR research protocols

Clinical transplantation

Pharmacotherapy

This page only lists publications with an associated author ORCID identifier.

Publications

Raymond L Heilman, James N Fleming, Sook H Park, Christabel Rebello, Steve Kleiboeker, John Holman, John J Friedewald
Clinical Value of Peripheral Blood Gene Expression Profile and dd-cfDNA for Identifying Persistent Rejection. Kidney360 (2024)
Robert B Ettenger, Michael E Seifert, Tom David Blydt-Hansen, David M Briscoe, John Holman, Patricia L Weng, Rachana Srivastava, James N Fleming, Mohammed Malekzadeh, Meghan Pearl
Detection of Subclinical Rejection in Pediatric Kidney Transplantation: Current and Future Practices. Pediatric transplantation 28 (6) (2024)
Heather L Kutzler, Alicia B Lichvar, David Quan, Lyndsey Bowman Anger, Adam Diamond, Christina Teeter Doligalski, Tina Griffin, Jennifer I Melaragno, Helen Sweiss, James N Fleming
A systematic review of opioid use and multimodal strategies in solid organ transplant recipients and living donors. Pharmacotherapy (2023)
Heather L Kutzler, Alicia B Lichvar, David Quan, Lyndsey J Bowman, Adam Diamond, Christina Teeter Doligalski, Tina Griffin, Jennifer Melaragno, Helen Sweiss, James N Fleming
A Systematic Review of Opioid Use and Multimodal Strategies in Solid Organ Transplant Recipients and Living Donors. Pharmacotherapy (2023)
James N Fleming, Timothy Cober, Janelle Hickey, Leslie Stach, Allison Kawano, Amanda Szczepanik, Alicia Watson, Yuka Imamura Kawasawa, Juston Weems, Patricia West-Thielke
Clinical Utility of the OmniGraf Biomarker Panel in the Care of Kidney Transplant Recipients (CLARITY): Protocol for a Prospective, Multisite Observational Study. JMIR research protocols 11 (12) (2022)
James N Fleming, Timothy Cober, Janelle Hickey, Leslie Stach, Allison Kawano, Amanda Szczepanik, Alicia Watson, Yuka Imamura Kawasawa, Juston Weems, Patricia West-Thielke
Clinical Utility of the OmniGraf Biomarker Panel in the Care of Kidney Transplant Recipients (CLARITY): Protocol for a Prospective, Multisite Observational Study. JMIR research protocols 11 (12) (2022)
James N Fleming, Timothy Cober, Janelle Hickey, Leslie Stach, Allison Kawano, Amanda Szczepanik, Alicia Watson, Yuka Imamura Kawasawa, Juston Weems, Patricia West-Thielke
Clinical Utility of the OmniGraf Biomarker Panel in the Care of Kidney Transplant Recipients (CLARITY): Protocol for a Prospective, Multisite Observational Study. JMIR research protocols 11 (12) (2022)
James N Fleming, Timothy Cober, Janelle Hickey, Leslie Stach, Allison Kawano, Amanda Szczepanik, Alicia Watson, Yuka Imamura Kawasawa, Juston Weems, Patricia West-Thielke
Clinical Utility of the OmniGraf Biomarker Panel in the Care of Kidney Transplant Recipients (CLARITY): Protocol for a Prospective, Multisite Observational Study. JMIR research protocols 11 (12) (2022)
David J Taber, James N Fleming, Zemin Su, Patrick Mauldin, John W McGillicuddy, Aurora Posadas, Mulugeta Gebregziabher
Significant hospitalization cost savings to the payer with a pharmacist-led mobile health intervention to improve medication safety in kidney transplant recipients. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 21 (10) (2021)
Vinayak S Rohan, David J Taber, Neha Patel, Caroline Perez, Nicole A Pilch, Sara Parks, Eric Bolin, Satish N Nadig, Prabhakar K Baliga, James N Fleming
Impact of a multidisciplinary multimodal opioid minimization initiative in kidney transplant recipients. Clinical transplantation 34 (10) (2020)
David J Taber, Aurora Posadas-Salas, Zemin Su, Vinaya Rao, Vinayak Rohan, Satish Nadig, John W McGillicuddy, Derek Dubay, James N Fleming
Preliminary assessment of safety and adherence to a once-daily immunosuppression regimen in kidney transplantation: Results of a randomized controlled pilot study. Clinical transplantation 34 (4) (2020)
Bailey Wise, Lytani Z Wilson, David J Taber, Nicole A Pilch, Vinayak Rohan, James N Fleming
The impact of pretransplant opioid exposure on healthcare utilization and costs in kidney transplant. Pharmacotherapy 41 (1) (2020)
R K Seeto, James N Fleming, Shamik Dholakia, Bethany L Dale
Understanding and using AlloSure donor derived cell-free DNA. Biophysical reviews 12 (4) (2020)
Zana Elmaasarani, Caitlin Mardis, Logan Gylten, David J Taber, James N Fleming, Neha Patel, Prabhakar Baliga, Vinaya Rao, Vinayak Rohan, Derek DuBay, Nicole A Pilch
Protocol-based nurse coordinator management of ambulatory tacrolimus dosing in de novo renal transplant recipients-A single-center experience with a large African American population. Clinical transplantation 33 (10) (2019)
James N Fleming, Frank A Treiber, John McGillicuddy, Gebregziabher Mulugeta, David J Taber
Improving Transplant Medication Safety Through a Pharmacist-Empowered, Patient-Centered, mHealth-Based Intervention: TRANSAFE Rx Study Protocol. JMIR research protocols 7 (3) (2018)
James N Fleming, David J Taber, Nicole A Weimert, Satish Nadig, John W McGillicuddy, Charles F Bratton, Prabhakar K Baliga, Kenneth D Chavin
Valganciclovir (VGCV) followed by cytomegalovirus (CMV) hyperimmune globulin compared to VGCV for 200 days in abdominal organ transplant recipients at high risk for CMV infection: A prospective, randomized pilot study. Transplant infectious disease : an official journal of the Transplantation Society 19 (6) (2018)
James N Fleming, Jennifer C Lai, Helen S Te, Adnan Said, Erin K Spengler, Shari S Rogal
Opioid and opioid substitution therapy in liver transplant candidates: A survey of center policies and practices. Clinical transplantation 31 (12) (2017)